Amentum's Nuclear Bet Faces Timeline Risk

Forward-Looking Analysis

Amentum Holdings projects $15.7 billion in revenue and $526.8 million in earnings by 2029. This forecast requires 3.4% yearly revenue growth and approximately a $379 million earnings increase from the current $148.0 million. Analysts derive a $32.17 fair value estimate, implying a 30% upside to the current stock price. However, some conservative estimates assume only 1.9% annual revenue growth and $549.5 million in 2029 earnings, reflecting concerns that nuclear project approval timelines may be longer than management’s planning horizon suggests.

Historical Performance Review

Amentum Holdings reported strong results in 2026Q2, generating $3.48 billion in revenue and $345.00 million in gross profit. Net income reached $54.00 million, supporting an EPS of $0.22. These figures demonstrate the company's ability to maintain profitability despite the complexities inherent in its long-cycle defense, space, and nuclear contracts, providing a solid baseline for upcoming quarters.

Additional News

On August 4, 2026, Westinghouse Electric Company announced agreements with Amentum to support its APX nuclear technology platform. This collaboration includes support for AP1000 fleet deployment, AP300 small modular reactor development and licensing, and joint work on delivering 1-gigawatt reactors at scale. Additionally, Amentum was appointed as the program delivery partner for Rolls Royce SMRs in the UK and Czech Republic. These roles deepen Amentum’s involvement across the nuclear project lifecycle, aligning its engineering and regulatory expertise with major technology providers to pursue repeatable, fleet-based reactor deployment worldwide.

Summary & Outlook

Amentum exhibits robust financial health with significant execution potential, anchored by a $47 billion backlog. The primary growth catalyst is its expanding role in the nuclear sector, specifically through SMR licensing and fleet deployment partnerships with Westinghouse and Rolls Royce. However, investors must weigh these opportunities against execution risks and regulatory delays, which could extend project timelines beyond current expectations. While the long-term narrative supports steady earnings conversion, near-term volatility may persist due to permitting uncertainties. We maintain a neutral-to-bullish stance, contingent on regulatory progress.